A 6-Month Safety, Efficacy, and Pharmacokinetic (PK) Trial of Delamanid in Pediatric Participants With Multidrug Resistant Tuberculosis (MDR-TB)
Clinical trial NCT01859923 · COMPLETED
Trial details
- NCT number
- NCT01859923
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-20
- Primary completion
- 2020-01-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.